Jacobs M J, Eijsman L, Meylaerts S A, Balm R, Legemate D A, de Haan P, Kalkman C J, de Mol B A
Department of Vascular Surgery, Academic Medical Center of the University of Amsterdam, The Netherlands.
Eur J Cardiothorac Surg. 1998 Aug;14(2):201-5. doi: 10.1016/s1010-7940(98)00164-x.
Renal failure and visceral ischemia are feared complications following thoracoabdominal aortic aneurysm (TAAA) repair, significantly contributing to mortality. This prospective study describes volume- and pressure-controlled perfusion of the renal and visceral arteries during TAAA surgery.
In 73 consecutive patients (mean age 59 years), TAAA repair (27 type I, 28 type II, 8 type III and 10 type IV) was performed, using retrograde and selective organ perfusion. Sixteen patients had impaired renal function with blood creatinine higher than 100 mmol/l. During the thoracic part of the procedure, the mean distal aortic pressure was kept above 60 mm Hg by means of left-heart bypass. After opening the abdominal aorta, the renal and visceral arteries were individually perfused by means of perfusion catheters (9 French) in the first 33 patients (group I). Volume flow through each catheter was assessed with ultrasound flow meters and maintained at least at 60 ml/min. In addition to volume flow measurements, catheters with pressure sensors were used in the last 40 patients (group II), allowing pressure-controlled selective perfusion. The extent of the aneurysm was comparable in both groups.
Mean cross-clamp time for the thoracic part was 46 min, including proximal anastomosis and reattachment of intercostal arteries. Mean cross-clamp time for the abdominal part was 74 min, including re-implantation of intestinal and renal arteries and selective dacron grafts to the celiac-axis arteries (n = 5), superior mesenteric arteries (n = 8) and renal arteries (n = 25), through which the catheters guaranteed continuous perfusion during the time the anastomosis was performed. Urine output was uninterrupted in all patients, irrespective of cross-clamp time. In group I, one patient (3%) developed renal failure and three patients (9%) required temporary peritoneal dialysis. In group II, no patients developed renal failure and two patients (5%) required temporary peritoneal dialysis. Thirteen patients with pre-existing renal impairment did not deteriorate. No patients developed visceral ischemia or multiple-organ failure. Total in-hospital mortality was 6/73 (8%) and was related to cardiopulmonary complications.
Renal and visceral ischemia can be reduced significantly by continuous perfusion during cross-clamping in TAAA repair. Not only sufficient volume flow but also adequate arterial pressure appears to be essential in maintaining renal function.
肾衰竭和内脏缺血是胸腹主动脉瘤(TAAA)修复术后令人担忧的并发症,对死亡率有显著影响。这项前瞻性研究描述了TAAA手术期间肾动脉和内脏动脉的容量控制和压力控制灌注。
对73例连续患者(平均年龄59岁)进行TAAA修复(27例I型、28例II型、8例III型和10例IV型),采用逆行和选择性器官灌注。16例患者肾功能受损,血肌酐高于100 mmol/l。在手术的胸部部分,通过左心旁路使远端主动脉平均压保持在60 mmHg以上。打开腹主动脉后,在前33例患者(I组)中通过灌注导管(9F)对肾动脉和内脏动脉进行单独灌注。用超声流量计评估通过每个导管的血流量,并维持至少60 ml/min。除血流量测量外,后40例患者(II组)使用带压力传感器的导管,实现压力控制的选择性灌注。两组患者的动脉瘤范围相当。
胸部部分的平均阻断时间为46分钟,包括近端吻合和肋间动脉重新附着。腹部部分的平均阻断时间为74分钟,包括肠动脉和肾动脉的重新植入以及对腹腔干动脉(n = 5)、肠系膜上动脉(n = 8)和肾动脉(n = 25)的选择性涤纶移植,导管在吻合过程中保证了持续灌注。所有患者尿量均未间断,与阻断时间无关。I组中,1例患者(3%)发生肾衰竭,3例患者(9%)需要临时腹膜透析。II组中,无患者发生肾衰竭,2例患者(5%)需要临时腹膜透析。13例术前肾功能受损的患者病情未恶化。无患者发生内脏缺血或多器官功能衰竭。住院总死亡率为6/73(8%),与心肺并发症有关。
在TAAA修复术中,通过阻断期间的持续灌注可显著减少肾和内脏缺血。维持肾功能不仅需要足够的血流量,而且适当的动脉压似乎也至关重要。